From professional translators, enterprises, web pages and freely available translation repositories.
ranibizumab.
ranibizumab.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
ranibizumab permitiu
ranibizumab allowed
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ranibizumab 0,5 mg (n=130)
ranibizumab 0.5 mg (n=130)
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
um ml contém 10 mg de ranibizumab.
one ml contains 10 mg of ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
contém a substância ativa designada ranibizumab.
it contains the active substance called ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lucentis 10 mg/ ml solução injectável ranibizumab
lucentis 10 mg/ ml solution for injection ranibizumab
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
a substância activa do lucentis é o ranibizumab.
the active substance in lucentis is ranibizumab.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
1 frasco para injetáveis = 2,3 mg ranibizumab.
1 vial = 2.3 mg ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
frasco para injetáveis contendo 2,3 mg de ranibizumab.
vial containing 2.3 mg of ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
grupo ranibizumab 0,5 mg por estabilização (n=105)
ranibizumab 0.5 mg group i by stabilisation (n=105)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lucentis 10 mg/ ml solução injectável ranibizumab uso intravítreo
lucentis 10 mg/ ml solution for injection ranibizumab intravitreal use
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
a substância ativa é o ranibizumab (10 mg/ml).
the active substance is ranibizumab (10 mg/ml).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
o lucentis é um medicamento que contém a substância ativa ranibizumab.
lucentis is a medicine that contains the active substance ranibizumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
não existem dados clínicos disponíveis sobre gravidezes expostas a ranibizumab.
for ranibizumab no clinical data on exposed pregnancies are available.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a administração intravítrea bilateral de ranibizumab a macacos cynomolgus em doses entre
bilateral intravitreal administration of ranibizumab to cynomolgus monkeys at doses between
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a segurança e a eficácia de ranibizumab não foram estudadas em doentes pediátricos.
the safety and efficacy of ranibizumab have not yet been studied in paediatric patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
este aumento da incidência foi comparável entre os doentes tratados com ranibizumab e eylea.
this increased incidence was comparable between patients treated with ranibizumab and eylea.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
cada frasco para injetáveis contém 2,3 mg de ranibizumab em 0,23 ml de solução.
each vial contains 2.3 mg of ranibizumab in 0.23 ml solution.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
o ranibizumab liga-se com elevada afinidade às isoformas do vegf-a (ex.
it binds with high affinity to the vegf-a isoforms (e.g.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
foram encontrados anticorpos do ranibizumab séricos e vítreos num sub-conjunto de animais tratados.
serum and vitreous antibodies to ranibizumab were found in a subset of treated animals.
Last Update: 2017-04-26
Usage Frequency: 4
Quality: